PLX PHARMA INC. — Form D

PLX PHARMA INC. of HOUSTON, TX, a company, filed a Form D exempt-offering notice with the SEC on 2016-03-11. The offering totals $2.0M, of which $1.3M was reported sold. Industry: Pharmaceuticals.

Offering

• Filed: 2016-03-11
• Form: D
• Accession: 0001291520-16-000002
• Industry: Pharmaceuticals
• Exemptions: 06b
• Total offering: $2.0M
• Amount sold: $1.3M
• Remaining: $703K
• Investors: 27
• Date of first sale: 2016-02-23
• Security types: debt
• Revenue range: $1 - $1,000,000
• SEC file number: 021-259059

Issuer

• Name: PLX PHARMA INC.
• CIK: 0001291520
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Address: 8285 EL RIO STREET, HOUSTON, TX, 77054
• Phone: 713-842-1249

Officers, directors & promoters (26)

Showing 25 of 26 people.

Other filings by this issuer (5)

More

• CIK 1291520 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search